National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021

National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021

BACKGROUND Aligned with World Health Organization (WHO) goals, Ukraine aims to eliminate viral hepatitis. While some data on viral hepatitis B and C prevalence exist among key populations, nationwide prevalence in the general population has never been assessed. AIM To assess the prevalence of viral...

Full description

Saved in:

Bibliographic Details
Main Author:	Olena Nesterova
Format:	Article
Language:	English
Published:	European Centre for Disease Prevention and Control 2025-07-01
Series:	Eurosurveillance
Subjects:	viral hepatitis hepatitis B virus surface antigen hepatitis D nationwide representative serosurvey hepatitis C hepatitis B
Online Access:	https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2025.30.29.2500015
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Regulation of viral hepatitis by N6-methyladenosine RNA methylation
by: Jae-Su Moon, et al.
Published: (2025-12-01)

Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation
by: Keyin Zheng, et al.
Published: (2025-06-01)

Virological and morphological relationships in the phases of the immune control and reactivation in patients with chronic hepatitis B
by: I. A. Gabdrakhmanov, et al.
Published: (2016-02-01)

Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01)

Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis
by: V. V. Karabaeva, et al.
Published: (2021-11-01)

The Prevalence of Occult Hepatitis B Virus Infection among Hepatitis B Surface Antigen Sero-negative Blood Donors
by: Babandina Muhammad Musa 1, Ocheme Julius Okojokwu 2, Musa Saleh Makeri 3, Khadijat Toyi Musa 4, Amos Dangana 5, Maryam Aladodo 6, Saheed Adekola 7, Nura Muhammad Bunza 8, Zainab Usman-kanfani9, Clara Obiegue 10, Abbas M Babandina11 Musa Abidemi Muhibi 12,
Published: (2025-05-01)

Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)

Chronic viral hepatitis B and D in pregnant women: course and outcomes (review)
by: M. D. Akhmedova, et al.
Published: (2021-07-01)

Seroprevalence Study of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus in Humans and Risk Factors in Suleja, Nigeria
by: Bello, Z., et al.
Published: (2017-12-01)

Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA
by: Hongyu Shen, et al.
Published: (2019-11-01)

Seroprevalence of hepatitis B surface antigen and hepatitis B e antigen among childbearing-age women in Mianyang, China
by: Min Wang, et al.
Published: (2015-07-01)

PREVALENCE OF MARKERS OF VIRAL HEPATITIS B AND D FROM HEALTHY POPULATION IN REPUBLIC TYVA
by: T. V. Kozhanova, et al.
Published: (2015-08-01)

Prevalence of hepatitis B virus infection and associated factors among adults intrafamilial household contacts attending antenatal care clinics in the Central Ethiopian region: from pregnant women index cases
by: Yilma Markos Larebo, et al.
Published: (2025-02-01)

Study on seroprevalence of hepatitis delta in a regional hospital in western Turkey
by: Sukran Kose, et al.
Published: (2012-11-01)

VIRAL HEPATITIS B AND C AS COMORBIDITY IN RHEUMATIC DISEASES: ANALYSIS OF THE DATA OF THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY CLINIC OVER 4 YEARS
by: A. E. Karateev, et al.
Published: (2016-07-01)

Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis
by: Elmas Pinar Kahraman Kilbas, et al.
Published: (2025-01-01)

Seroprevalence of antibodies to hepatitis A, B and C viruses across all age groups in Chonburi Province, Thailand, 2022–2023
by: Nasamon Wanlapakorn, et al.
Published: (2025-12-01)

Hepatitis B and C infections among lymphoma patients: a national study in the Republic of Moldova
by: Ivan Negara, et al.
Published: (2022-12-01)

Identification of hepatitis B virus mutations in patients with hepatocellular carcinoma
by: A. A. Grishaeva, et al.
Published: (2025-02-01)

Evaluation of the Effectiveness of Hepatitis B Vaccination in Children Aged 1 to 14 Years in Sulaimani City
by: Razhan Sabah Hassan, et al.
Published: (2023-04-01)

Seroprevalence to Hepatitis B Virus among Prisoners Taking into Account Age, HIV Status, and Injection Drug Use
by: M. V. Piterskiy, et al.
Published: (2024-03-01)

Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects
by: Mateusz Litwin Litwin, et al.
Published: (2025-01-01)

Prevalence of overt and occult hepatitis B viral infection among pregnant women attending antenatal clinics in Edo state university teaching hospital Auchi, Nigeria
by: Bukhari Isah Shuaib, et al.
Published: (2024-12-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)

Viral hepatitis
by: D. Brink
Published: (2006-09-01)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
by: Ying Lu, et al.
Published: (2021-01-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Occult hepatitis B- viral infections among blood donors in Duhok-Iraq
by: Noor Rizqo Mikha, et al.
Published: (2025-03-01)

Decreasing hepatitis B seroprevalence in pregnant women in Taiwan between 2016 and 2021: a claim-based cohort study
by: Li-Nien Chien, et al.
Published: (2025-01-01)

Viral load in chronic hepatitis b: correlation with laboratory and morphological parameters
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women attending a tertiary care hospital in Mogadishu, Somalia, 2017–2021
by: Mohamed Abdulkadir Hassan-Kadle, et al.
Published: (2025-07-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01)

Viral hepatitis in children: state and prospects for solving the problem
by: L. G. Goriacheva, et al.
Published: (2021-12-01)

ETIOTROPIC THERAPY OF VIRAL HEPATITIS
by: S. B. Chuelov, et al.
Published: (2017-09-01)

Oxidative stress in viral hepatitis
by: Huseyin Erdal, et al.
Published: (2024-04-01)

Serologic and molecular characteristics of hepatitis B virus infection in vaccinated schizophrenia patients in China
by: Yiying Wang, et al.
Published: (2016-04-01)

CHRONIC VIRAL HEPATITIS В AND C IN CHILDREN BORN FROM MOTHERS INFECTED WITH НВV AND HCV
by: T. I. Raba
Published: (2017-03-01)